SNT
Click for more information
0.00% 3.5¢ syntara limited

Ann: Pharmaxis Drug Study Published in Nature Communications, page-9

  1. ContangoPhil
    125 Posts.
    lightbulb Created with Sketch. 5
    clock Created with Sketch.
    12/04/23
    13:53
    Post #: 67236385
    Using limited fund's wisely in not pursuing heptocellular study for now. Need some postive results sooner rather than later otherwise will end up at 3 cents. Some good news for PXS.
    PXS Price at posting: 4.9¢ Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HAR Haranga Resources reports significant resource upgrade at Saraya Uranium Project
right-arrow Created with Sketch.
NEWS Why are so many ASX explorers setting up shop in Saudi Arabia? + 8 stocks to watch
right-arrow Created with Sketch.
JAV Javelin increases the resource of Coogee in WA by 158%
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions
right-arrow Created with Sketch.
PLS Pilbara blames low lithium prices for 89% drop in profit for FY24
right-arrow Created with Sketch.
RDN Raiden gears up for exploration in final quarter of 2024
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $45.16M
Open High Low Value Volume
3.6¢ 3.6¢ 3.3¢ $58.54K 1.668M

Buyers (Bids)

No. Vol. Price($)
1 5226 3.5¢
 

Sellers (Offers)

Price($) Vol. No.
3.6¢ 969288 2
View Market Depth
Last trade - 16.10pm 27/08/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.